Sexual Health Lab Panels
Sexual health peptides like PT-141, Oxytocin, and Melanotan II are powerful tools for studying libido and sexual function in preclinical research. PT-141, a melanocortin agonist, revs up arousal by targeting brain and vascular pathways in experimental models. Oxytocin, the “bonding hormone,” enhances intimacy and relaxation responses in studies. Melanotan II boosts libido and pigmentation via melanocortin receptors, offering dual endpoints for investigation. But these peptides don’t act in a vacuum—they tweak hormones, circulation, and stress systems, so researchers need a solid monitoring setup. These lab panels act as a research toolkit, tracking testosterone, estrogen, and nitric oxide to confirm sexual enhancements, while checking liver, kidney, and inflammation markers to ensure model safety. They catch variables like cortisol spikes or electrolyte shifts early, so your data stays clean and your experiments stay on track.
What’s Included:
Complete Blood Count (CBC)
- Reason: Provides a broad hematological profile (red blood cells, white blood cells, platelets) in research models. Peptides like Melanotan II (affecting pigmentation and circulation) and PT-141 (influencing vascular responses) may alter blood dynamics. This test ensures stability in experimental systems and detects any hematological shifts due to peptide activity.
Comprehensive Metabolic Panel (CMP)
- Reason: Assesses liver (ALT, AST), kidney (creatinine, BUN), glucose, and electrolyte function in preclinical models. These peptides are metabolized by the liver and excreted renally, and Oxytocin may influence glucose via stress pathways. Monitoring ensures organ health and metabolic balance under experimental conditions.
Testosterone (Total and Free)
- Reason: Measures androgen levels critical to sexual function in research subjects. PT-141 and Melanotan II enhance libido via melanocortin pathways, potentially interacting with testosterone. This test evaluates hormonal effects, ensuring peptides modulate sexual responses without disrupting endocrine balance.
Estrogen (Estradiol)
- Reason: Tracks estrogen levels, which influence sexual health in both male and female models. Oxytocin and PT-141 may affect reproductive hormones indirectly via hypothalamic-pituitary signaling. This panel ensures estrogen regulation aligns with sexual function research goals.
Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH)
- Reason: Assesses pituitary hormones that regulate gonadal function. Melanotan II and PT-141 (melanocortin agonists) may stimulate LH release, impacting testosterone or estrogen production. Monitoring ensures pituitary responses are consistent with sexual enhancement effects in studies.
Prolactin
- Reason: Evaluates prolactin levels, which can suppress libido if elevated. Oxytocin influences prolactin via oxytocinergic pathways, while PT-141’s effects may counteract prolactin-related inhibition. This test ensures sexual function improvements aren’t offset by hormonal imbalances in models.
Cortisol
- Reason: Measures stress hormone responses in experimental systems. Oxytocin reduces cortisol to promote bonding and relaxation, while PT-141 and Melanotan II may influence stress via melanocortin receptors. This panel confirms stress modulation supports sexual health outcomes in research.
Thyroid Panel (TSH, Free T3, Free T4)
- Reason: Assesses thyroid function, which affects metabolism and libido. Melanotan II’s systemic effects and Oxytocin’s neuroendocrine role may interact with thyroid pathways. Monitoring ensures thyroid stability, as imbalances could confound sexual function data
C-Reactive Protein (CRP)
- Reason: Gauges systemic inflammation in preclinical models. Chronic inflammation can impair sexual function, and Oxytocin’s anti-inflammatory properties may mitigate this. This test confirms inflammation is controlled, supporting sexual health research outcomes.
Lipid Panel (Cholesterol, HDL, LDL, Triglycerides)
- Reason: Monitors cardiovascular health tied to sexual function. Melanotan II and PT-141 influence circulation, potentially affecting lipid metabolism. This panel ensures vascular health aligns with sexual enhancement goals in experimental settings.
Electrolytes (Sodium, Potassium, Calcium, Magnesium)
- Reason: Checks mineral balance critical for nerve and muscle function. PT-141’s vascular effects and Oxytocin’s role in smooth muscle contraction (e.g., orgasm) rely on stable electrolytes. This test prevents imbalances that could skew sexual response data.
Suggested Testing Frequency for Research
- Baseline (Pre-Study): Establishes control values in experimental models.
- 4-6 Weeks Into Study: Assesses initial responses to peptides.
- Every 3-6 Months (Long-Term Studies): Monitors sustained effects and safety.
- Post-Study: Evaluates recovery or persistent changes after peptide cessation.
